From: Synthetic cannabinoids impact on cognitive functions
SCID-I and SCID-II scales
SC n (%)
Schizophrenia
9 (30%)
Bipolar affective disorder
7 (23.3%)
Major Depressive disorder
1 (3.3%)
Antisocial personality disorder
19 (63.3%)
Borderline personality disorder
27 (90%)